![Sahil Kirpekar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sahil Kirpekar
Vorstandsvorsitzender bei
Reunion Neuroscience, Inc.
Vermögen: 523 831 $ am 31.05.2026
Profil
Sahil V.
Kirpekar is currently President, Chief Executive Officer & Director at Reunion Neuroscience, Inc. since 2026.
Formerly, served as Director at IntelGenx Technologies Corp.
from 2023 to 2024, Chief Business Officer at Atai Beckley NV from 2022 to 2025, and Head-Business Development at Otsuka Pharmaceutical Co., Ltd. Education includes graduate studies at the University of Cambridge.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,03 % | 15.09.2025 | 115.636 ( 0,03 % ) | 523 831 $ | 31.05.2026 |
Aktive Positionen von Sahil Kirpekar
| Unternehmen | Position | Beginn |
|---|---|---|
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Vorstandsvorsitzender | 15.06.2026 |
Ehemalige bekannte Positionen von Sahil Kirpekar
| Unternehmen | Position | Ende |
|---|---|---|
ATAI Life Sciences NV
 ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Corporate Officer/Principal | 02.04.2025 |
| INTELGENX TECHNOLOGIES CORP. | Direktor/Vorstandsmitglied | 17.05.2024 |
Otsuka Pharmaceutical Co., Ltd.
 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and nutraceuticals | Corporate Officer/Principal | - |
Ausbildung von Sahil Kirpekar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and nutraceuticals | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IntelGenx Technologies Corp.
 IntelGenx Technologies Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops and manufactures oral film therapeutics | Health Technology |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
